Susquehanna International Group Ltd. Kamada LTD Transaction History

Susquehanna International Group Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.22 - $5.85 $14,972 - $20,755	3,548 Added 34.7%	13,773 $63,000
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $66,213 - $83,041	-12,194 Reduced 54.39%	10,225 $57,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $22,085 - $28,909	-4,239 Reduced 15.9%	22,419 $148,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $139,954 - $156,482	26,658 New	26,658 $141,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.